Oracle Corporation $ORCL Holdings Raised by Cigna Investments Inc. New

Cigna Investments Inc. New boosted its stake in Oracle Corporation (NYSE:ORCL) by 0.8% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 16,313 shares of the enterprise software provider’s stock after buying an additional 124 shares during the quarter. Oracle makes up about 0.6% of Cigna Investments Inc. New’s holdings, making the stock its 24th biggest position. Cigna Investments Inc. New’s holdings in Oracle were worth $3,567,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Redmont Wealth Advisors LLC bought a new position in shares of Oracle during the 1st quarter valued at $27,000. Inlight Wealth Management LLC bought a new position in shares of Oracle during the 1st quarter valued at $28,000. Iron Horse Wealth Management LLC raised its holdings in shares of Oracle by 284.9% during the 1st quarter. Iron Horse Wealth Management LLC now owns 204 shares of the enterprise software provider’s stock valued at $29,000 after purchasing an additional 151 shares in the last quarter. Family Legacy Financial Solutions LLC bought a new position in shares of Oracle during the 2nd quarter valued at $60,000. Finally, Graybill Wealth Management LTD. bought a new position in shares of Oracle during the 1st quarter valued at $39,000. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Oracle Stock Performance

NYSE ORCL opened at $314.90 on Wednesday. The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62. The firm has a market capitalization of $894.84 billion, a price-to-earnings ratio of 72.89, a P/E/G ratio of 3.55 and a beta of 1.46. The company’s fifty day moving average is $255.23 and its two-hundred day moving average is $197.74. Oracle Corporation has a 52-week low of $118.86 and a 52-week high of $345.72.

Oracle (NYSE:ORCL) last posted its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.48 by ($0.01). The company had revenue of $14.93 billion during the quarter, compared to analyst estimates of $15.04 billion. Oracle had a return on equity of 72.93% and a net margin of 21.08%.The business’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.39 earnings per share. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Equities research analysts forecast that Oracle Corporation will post 5 EPS for the current year.

Oracle Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Thursday, October 9th. Oracle’s payout ratio is 46.30%.

Insider Buying and Selling at Oracle

In other news, insider Clayton M. Magouyrk sold 21,241 shares of Oracle stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $297.11, for a total transaction of $6,310,913.51. Following the sale, the insider directly owned 78,000 shares in the company, valued at approximately $23,174,580. The trade was a 21.40% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William G. Parrett sold 11,500 shares of Oracle stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $306.00, for a total transaction of $3,519,000.00. Following the sale, the director owned 17,764 shares in the company, valued at approximately $5,435,784. This trade represents a 39.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 112,092 shares of company stock worth $32,960,165 in the last 90 days. 42.20% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of research firms have recently weighed in on ORCL. BNP Paribas set a $377.00 price target on shares of Oracle in a report on Wednesday, September 10th. Loop Capital set a $135.00 price target on shares of Oracle in a report on Tuesday, June 10th. Sanford C. Bernstein restated an “outperform” rating on shares of Oracle in a report on Thursday, September 11th. Stifel Nicolaus raised their price target on shares of Oracle from $250.00 to $350.00 and gave the company a “buy” rating in a report on Wednesday, September 10th. Finally, Guggenheim lifted their target price on shares of Oracle from $250.00 to $375.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. Two research analysts have rated the stock with a Strong Buy rating, twenty-five have issued a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $305.75.

Oracle Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.